Evidence-based guidelines for empirical therapy of neutropenic fever in Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, D.-G. | - |
dc.contributor.author | Kim, S.-H. | - |
dc.contributor.author | Kim, S.Y. | - |
dc.contributor.author | Kim, C.-J. | - |
dc.contributor.author | Min, C.-K. | - |
dc.contributor.author | Park, W.B. | - |
dc.contributor.author | Park, Y.-J. | - |
dc.contributor.author | Song, Y.G. | - |
dc.contributor.author | Jang, J.-S. | - |
dc.contributor.author | Jang, J.H. | - |
dc.contributor.author | Jin, J.Y. | - |
dc.contributor.author | Choi, J.-H. | - |
dc.date.available | 2019-05-30T00:21:06Z | - |
dc.date.issued | 2011-08 | - |
dc.identifier.issn | 2093-2340 | - |
dc.identifier.issn | 2092-6448 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/21909 | - |
dc.description.abstract | Neutrophils play an important role in immunological function. Neutropenic patients are vulnerable to infection, and except fever is present, inflammatory reactions are scarce in many cases. Additionally, because infections can worsen rapidly, early evaluation and treatments are especially important in febrile neutropenic patients. In cases in which febrile neutropenia is anticipated due to anticancer chemotherapy, antibiotic prophylaxis can be used, based on the risk of infection. Antifungal prophylaxis may also be considered if long-term neutropenia or mucosal damage is expected. When fever is observed in patients suspected to have neutropenia, an adequate physical examination and blood and sputum cultures should be performed. Initial antibiotics should be chosen by considering the risk of complications following the infection; if the risk is low, oral antibiotics can be used. For initial intravenous antibiotics, monotherapy with a broadspectrum antibiotic or combination therapy with two antibiotics is recommended. At 3 5 days after beginning the initial antibiotic therapy, the condition of the patient is assessed again to determine whether the fever has subsided or symptoms have worsened. If the patient's condition has improved, intravenous antibiotics can be replaced with oral antibiotics; if the condition has deteriorated, a change of antibiotics or addition of antifungal agents should be considered. If the causative microorganism is identified, initial antimicrobial or antifungal agents should be changed accordingly. When the cause is not detected, the initial agents should continue to be used until the neutrophil count recovers. © 2011 by The Korean Society of Infectious Diseases. | - |
dc.format.extent | 37 | - |
dc.language | 한국어 | - |
dc.language.iso | KOR | - |
dc.publisher | 대한감염학회 | - |
dc.title | Evidence-based guidelines for empirical therapy of neutropenic fever in Korea | - |
dc.title.alternative | Evidence-based Guidelines for Empirical Therapy of Neutropenic Fever in Korea | - |
dc.type | Article | - |
dc.identifier.doi | 10.3947/ic.2011.43.4.285 | - |
dc.identifier.bibliographicCitation | Infection and Chemotherapy, v.43, no.4, pp 285 - 321 | - |
dc.identifier.kciid | ART001578618 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-84863549165 | - |
dc.citation.endPage | 321 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 285 | - |
dc.citation.title | Infection and Chemotherapy | - |
dc.citation.volume | 43 | - |
dc.type.docType | Article | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Fever | - |
dc.subject.keywordAuthor | Korea | - |
dc.subject.keywordAuthor | Neutropenia | - |
dc.subject.keywordAuthor | Practice guideline | - |
dc.subject.keywordPlus | antibiotic agent | - |
dc.subject.keywordPlus | antifungal agent | - |
dc.subject.keywordPlus | antineoplastic agent | - |
dc.subject.keywordPlus | add on therapy | - |
dc.subject.keywordPlus | antibiotic therapy | - |
dc.subject.keywordPlus | article | - |
dc.subject.keywordPlus | blood examination | - |
dc.subject.keywordPlus | cancer chemotherapy | - |
dc.subject.keywordPlus | evidence based practice | - |
dc.subject.keywordPlus | febrile neutropenia | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | infection risk | - |
dc.subject.keywordPlus | Korea | - |
dc.subject.keywordPlus | monotherapy | - |
dc.subject.keywordPlus | physical examination | - |
dc.subject.keywordPlus | prophylaxis | - |
dc.subject.keywordPlus | sputum analysis | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.